The Global Fund PSC brings the voice, knowledge and expertise of the private sector to the leading funding agency in global health to combat the deadliest infectious diseases.
The private sector plays a pivotal role in the Global Fund, advancing innovation in products and programs, contributing funding and technical expertise, and providing training, governance and advocacy to enhance the impact of global health initiatives.
The PSC holds one of the 20 voting board seats of the Global Fund. Over the years, representatives of the PSC have worked on Board Committees and Working Groups to guide Global Fund policies and priorities and maximize the impact of Global Fund-supported programs to end AIDS, TB and malaria by bringing the insights of the corporate sector to four key areas: strategy and governance, advocacy, mobilization, and organized action.
-
PSC holds one of the 20 voting seats of the Global Fund’s Board. PSC elects the private sector’s voting Board Member and Alternate Board Member to the Global Fund.
Elected PSC members also participate in Global Fund’s committees, ensuring that Global Fund initiatives actively engage the business sector, while bringing assets and core expertise to help improve the Global Fund’s efficiency.
-
Members engage in high-level meetings and events with government, NGOs and Global Fund representatives. PSC also leverages learnings from each member to nurture a compelling narrative for further private sector engagement on elimination of the three diseases.
-
Private sector and other nongovernment partners have contributed over US$2.7 billion as of July 2019 to expand the reach of Global Fund investments and save millions of lives. The role the private sector plays and its contributions have significantly increased since the Global Fund's founding. PSC is particularly active around the Global Fund’s Replenishments through direct contributions of some of its members and mobilization efforts directed to traditional donors.
-
PSC is coordinated by a Focal Point organization, currently the High Lantern Group (HLG). As the Focal Point, HLG works with businesses willing to contribute their expertise, advise the Board's deliberations, ensures ongoing relations with the Global Fund and advocates for the role of business in global health.
Our Work
-
Sherwin Charles is a co-founder of Goodbye Malaria and serves as its Chief Executive Officer. He has more than a decade of experience in the banking and financial services industry and began his career at Ernst & Young. He helped Nando’s international restaurant group become one of the first African corporations to contribute to the Global Fund.
-
Alternate Board Member
Silas Holland is the Executive Director of Infectious Disease and Neuroscience Policy at Merck & Co., Inc., based in Washington, D.C. He leads Merck’s global public policy initiatives and advocacy on infectious diseases, including HIV treatment and prevention, COVID-19 therapeutics, pandemic preparedness, and he oversees policy initiatives in neuroscience and ophthalmology.
-
Mario leads the PSC Focal Point. Mario is the Founder & Managing Director of Eleveya, a strategic positioning firm and convening platform operating at the nexus of strategy, public affairs and coalition development.
Leadership Team
PSC holds one of the 20 voting seats of the Global Fund Board. Fellow board members include representatives from all the other constituencies. PSC elects its officials every two years and it’s supported by a focal point organization.
Our Engagement
Participation in Global Fund Committees
Strategy
The Strategy Committee (SC) provides oversight of the strategic direction of the Global Fund and ensures the optimal impact and performance of its investments in health.
Ethics & Governance
The Ethics and Governance Committee (EGC) ensures that the Global Fund and its stakeholders adhere to appropriate standards of ethical behavior. It oversees implementation of the procedures and operations related to the Global Fund’s governance structure and its core governance functions. While EGC members are nominated by Global Fund constituencies, they serve in their personal capacity. From June 2025 PSC will be represented on this committee by Shamit Shah, CEO, Freight in Time.
Audit & Finance
The Audit and Finance Committee (AFC) ensures optimal performance of the corporate and financial operations of the Global Fund. It provides oversight of the financial management of the Global Fund’s resources, the internal and external audit functions, and oversees the investigation functions of the Global Fund. From June 2025 PSC member Sherwin Charles will chair the AFC. PSC is also represented on the Audit & Finance Committee by Patrick Sieyes, Vestergaard.
